Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
Mechano growth factor (MGF) is a splice variant of the insulin-like growth factor 1 (IGF-1) gene that has drawn sustained interest in muscle and tissue biology laboratories. Rather than being a separate gene product, MGF arises from alternative splicing of the same IGF-1 transcript that yields circulating IGF-1. What makes it distinct is its responsiveness to mechanical input: expression of this isoform rises sharply in skeletal muscle after mechanical loading, stretch, or damage, which is the reason early investigators named it “mechano growth factor.” Preclinical work has positioned MGF as a local, early signal within the broader IGF-1 axis, studied for its association with satellite cell activation and the initial phases of tissue repair.
This overview summarizes how MGF is defined at the molecular level, how it relates to mature IGF-1 and to laboratory analogs such as IGF-1 LR3, and which pathways researchers have examined in in-vitro and animal models. MGF is discussed here strictly as a research subject. It is not offered as a product in this catalog, and nothing below should be read as a description of human use, dosing, or therapeutic effect. For laboratories working on the IGF-1 signaling family, the closest related reference material available is IGF-1 LR3, a modified IGF-1 analog described later in this article.
What Is Mechano Growth Factor?
MGF corresponds to a specific isoform of the IGF-1 gene. In humans this mechanically responsive isoform is generally designated IGF-1Ec, while the rodent equivalent is often labeled IGF-1Eb. Both are produced by alternative splicing events that alter the carboxy-terminal region of the propeptide, known as the E-domain. The pioneering characterization of this isoform is widely attributed to Geoffrey Goldspink and colleagues, whose work in the 1990s and 2000s described how mechanical overload in muscle shifts splicing toward the MGF form.
The IGF-1 Gene and Alternative Splicing
The IGF-1 gene can be spliced into several isoforms that share the same mature IGF-1 core but differ in their trailing E-domain sequences. Inclusion of a particular exon introduces a reading-frame change that produces the unique MGF E-domain. Because the mature IGF-1 portion is common to these transcripts, the functional interest in MGF centers on the E-peptide: the short, isoform-specific segment that is not present in the same form in systemic IGF-1.
The Unique E-Domain Peptide
The MGF E-peptide is a short carboxy-terminal sequence, commonly described as roughly 24 amino acids in the human isoform. Laboratory studies have examined this synthetic E-peptide separately from the full growth factor, in part to ask whether it carries actions distinct from mature IGF-1. A recurring observation in preclinical models is that the MGF E-peptide appears to influence muscle precursor cells through a mechanism that may not depend on classical binding to the IGF-1 receptor, a point that continues to be investigated. Some research programs have also studied stabilized or pegylated forms of the E-peptide to extend its working stability in vitro.
MGF Compared With Mature IGF-1 and IGF-1 LR3
Placing MGF alongside mature IGF-1 and the widely studied analog IGF-1 LR3 helps clarify where each sits within the same signaling family. The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Attribute | MGF E-peptide | Mature IGF-1 | IGF-1 LR3 |
|---|---|---|---|
| Class | IGF-1 splice-variant E-peptide | IGF family growth factor | Modified IGF-1 analog |
| Approx. sequence length | ~24 amino acids (E-peptide) | 70 amino acids | 83 amino acids |
| Approx. molecular weight | ~2.8 kDa | ~7.6 kDa | ~9.1 kDa |
| Molecular origin | Alternative splicing of the IGF-1 gene | Mature product of the IGF-1 gene | Recombinant IGF-1 with an Arg substitution at position 3 and an N-terminal extension |
| Primary research context | Mechano-transduction and satellite cell activation | Local and systemic growth signaling | Extended-stability IGF-1 receptor signaling studies |
The practical takeaway for researchers is that these three entities are related but not interchangeable. Mature IGF-1 is the shared core, MGF represents an early mechanically induced splice signal centered on its unique E-peptide, and IGF-1 LR3 is an engineered analog designed for prolonged receptor-level signaling in experimental systems. Laboratories comparing IGF-axis compounds often place MGF and IGF-1 LR3 at opposite ends of a spectrum, from a transient local signal to a long-acting analog.
Pathways Studied in Preclinical Models
Most of what is understood about MGF comes from cell culture and animal research focused on skeletal muscle, with additional exploratory work in cardiac and neural tissue. Across these models, MGF is generally framed as a rapid, local responder rather than a systemic hormone.
Satellite Cell Activation
Satellite cells are the resident stem cells of skeletal muscle, and their activation is a central theme in MGF research. Preclinical studies have reported that the MGF E-peptide can promote the proliferation of muscle precursor cells while delaying their differentiation, a pattern interpreted as expanding the pool of available cells before repair proceeds. This positions MGF within the same tissue-repair conversation as other recovery-oriented research peptides; a broader survey is available in this recovery and tissue-repair overview.
Local Versus Systemic Signaling
A defining feature reported in the literature is timing. After mechanical loading or injury in animal models, the MGF isoform tends to appear first and transiently, ahead of the more sustained expression of systemic IGF-1. This temporal separation is one reason the two are studied as distinct signals despite sharing a gene. Investigations in non-muscle tissue, including models of cardiac stress and cerebral ischemia, have asked whether the E-peptide exerts protective or regenerative effects, though these remain preclinical and mechanistic in nature. All materials referenced are for research use only, not for human consumption.
Research Handling and Quality Considerations
Because MGF and related IGF-axis peptides are studied as sensitive biologics, documentation and handling quality matter for reproducible work. Peptides in this class are typically supplied as lyophilized powder and are sensitive to heat and repeated freeze-thaw cycles. Analytical documentation is essential: reviewing a certificate of analysis for identity and purity is a standard first step, and the COA and purity guide explains how to interpret those reports. Independent third-party certificates add a further layer of verification.
Sourcing practices also influence data quality. Selecting a supplier with transparent testing is covered in this guide to choosing a research peptide supplier. While MGF itself is not stocked here, researchers studying the IGF-1 pathway can review the closest available reference material, IGF-1 LR3, or browse the full research peptide catalog.
Frequently Asked Questions
What is mechano growth factor (MGF)?
Mechano growth factor is a splice variant of the IGF-1 gene that is upregulated in skeletal muscle following mechanical loading or damage. It shares the mature IGF-1 core but carries a unique carboxy-terminal E-domain peptide, and it is studied in preclinical models as an early, local signal in muscle biology.
Is MGF the same as IGF-1?
No. MGF and mature IGF-1 originate from the same gene, but MGF is a distinct splice isoform (designated IGF-1Ec in humans) with a different E-domain. Its research interest centers on the isoform-specific E-peptide, which is examined separately from the shared IGF-1 core.
Why is it called mechano growth factor?
The name reflects its behavior in research models: expression of this IGF-1 isoform rises in response to mechanical stimuli such as loading, stretch, and tissue damage. The term was adopted by early investigators who observed this mechanically driven splicing pattern in muscle.
How does MGF differ from IGF-1 LR3?
IGF-1 LR3 is an engineered IGF-1 analog with an arginine substitution and an N-terminal extension, designed for prolonged receptor-level signaling in experimental systems. MGF, by contrast, is a naturally occurring splice variant studied for a transient, mechanically induced local signal. The two sit at different points within the IGF-1 research family.
What pathways is MGF studied for?
Preclinical research has focused on satellite cell activation and early muscle repair signaling, with additional exploratory studies in cardiac and neural tissue. These investigations are mechanistic and conducted in vitro or in animal models only.
Is MGF available for purchase from Rejuven8 Peptides?
MGF is not part of the current catalog and is discussed here for educational purposes only. Laboratories studying the IGF-1 signaling axis can review the related analog IGF-1 LR3 or browse the full research peptide selection for available materials.
References and Further Reading
- Goldspink G, and colleagues. Foundational characterization of mechano growth factor and mechanically induced IGF-1 splicing in muscle. PubMed: mechano growth factor
- Yang SY, Goldspink G. Studies on the MGF E-domain peptide and muscle precursor cell proliferation. PubMed: MGF E domain satellite cells
- Hameed M, Harridge SDR, Goldspink G. IGF-1 splice variants and mechanical loading in skeletal muscle. PubMed: IGF-1 splice variant mechanical loading
- Research on the IGF-1Ec isoform and E-peptide signaling. PubMed: IGF-1Ec isoform
- Preclinical studies of the MGF E-peptide in satellite cell activation and muscle repair. PubMed: mechano growth factor satellite cells
- Exploratory work on the MGF E-peptide in cardiac and cerebral ischemia models. PubMed: mechano growth factor neuroprotection
- Comparative studies of Long R3 IGF-1 (IGF-1 LR3) in experimental systems. PubMed: Long R3 IGF-1
